Article

Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy

2019-03-26

Abstract excerpt

Psoriasis is a chronic immune-mediated inflammatory disease. Up to 40% of patients with psoriasis may develop psoriatic arthritis. Currently, interleukin (IL)-17/IL-23 pathways are identified as key factors in the immunopathogenesis of both conditions. Here we describe the case of a patient who developed psoriasiform skin lesions 10 months after the initiation of anti-IL17 therapy for psoriatic arthritis. The und...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 37a6ae10-b28c-5c25-a993-20fd0a6466bd
DOI: 10.12688/f1000research.18493.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapyDOI 10.12688/f1000research.18493.1Read

Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.Semantic proximity Read

Case report: Successful treatment with spesolimab of acrodermatitis continua of Hallopeau in an older patient without IL36RN mutations.Semantic proximity Read

Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic Factors.Semantic proximity Read

A unique combination of Generalised Pustular Psoriasis (GPP), Acrodermatitis Continua of Hallopeau (ACH), and psoriatic arthritis (both axial and peripheral) in a young male – a case-based review in literatureSemantic proximity Read

T-helper immune phenotype may underlie 'paradoxical' tumour necrosis factor-α inhibitor therapy-related psoriasiform dermatitis.Semantic proximity Read

IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies.Semantic proximity Read

A case of generalized psoriasiform and pustular eruption induced by infliximab: evidence for skin-homing Th17 in the pathogenesis.Semantic proximity Read

Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis.Semantic proximity Read

Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumabSemantic proximity Read

IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?Semantic proximity Read

[Update in the pathogenesis of psoriatic arthritis].Semantic proximity Read

Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers.Semantic proximity Read